Alexander White

Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial

T. Schnitzer, M. Hochberg, J. Carrino, 2021, Arthritis & rheumatology.

New strategies for the synthesis and functionalization of tetrahydroxanthones

G. Clarkson, M. Shipman, Penelope A. Turner, 2015 .

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study

A. Guermazi, D. Hunter, T. Neogi, 2022, Arthritis Research & Therapy.